Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Leukemia Research|August 25, 2022
Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutationHuan Chen, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Leukemia & Lymphoma|November 1, 2012
PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromesYa-Zhen Qin, Hong-Hu Zhu, Yan-Rong Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2013
[A multicenter comparison study on the quantitative detection of bcr-abl (P210) transcript levels in China]Ya-zhen Qin, Hui Cheng, Jian-nong Cen, et al.
Leukemia Research|April 23, 2013
NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypesYan-Rong Liu, Hong-Hu Zhu, Guo-Rui Ruan, et al.
British Journal of Haematology|August 18, 2021
PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort studyFei-Fei Tang, Sheng-Ye Lu, Xiao-Su Zhao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 22, 2010
[Abnormal expression of programmed cell death 5 gene in multiple myeloma patients]Li Bao, Guo-Rui Ruan, Xi-Jing Lu, et al.
Oncotarget|April 19, 2017
Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogeneticsShu-Juan Wang, Ping-Zhang Wang, Robert Peter Gale, et al.
Clinical Transplantation|July 5, 2024
Cytology or Multiparameter Flow Cytometry Positivity in the Cerebrospinal Fluid Before Transplantation is Predictive of Poor Outcomes After Allotransplantation in Acute Myeloid Leukemia PatientsLi-Juan Hu, Guo-Mei Fu, Yuan-Yuan Zhang, et al.
Leukemia & Lymphoma|July 1, 2021
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemiaHao Jiang, Xiao-Hong Liu, Jun Kong, et al.
British Journal of Haematology|April 27, 2024
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapyFei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, et al.
Pageof 17